wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 6. no 2. June 2001  
 TABLE OF CONTENT

 Original articles
The influence of budesonide on bone metabolism in children with asthma
Alina Puchnarewicz, Jolanta Tobolczyk, Marek Szczepański 2 , Danuta Rutkowska-Rogacz, Jerzy Hofman

The aim of study was to evaluate the influence of inhaled budesonide on selected parameters of bone metabolism (carboxyterminal propeptid of type I procollagen (PICP), carboxyterminal piridinoline crosslinked telopeptide of type I collagen (ICTP), and osteocalcin. The study included 25 children with chronic mild bronchial asthma (aged 4-17 years, mean: 11,2 years). Children were treated with inhaled budesonide at the dose of 1200µg/day for 14 days, then 800µg/day for 10 weeks, thereafter 400 µg/day for 3 months. Serum levels of PICP, ICTP were determined with radioimmunoassay (RIA, Orion Diagnostica). Osteocalcin was measured using a commercial OSTK-PR radioimmunoassay (Cis, Gif sur Yvette. France). Blood samples were collected after 3 and 6 months of treatment.
Osteocalcin (136.7±61.4µg/L) and PICP (459.4±161.5µg/L) concentrations were significantly decreased after 3 months of treatment in comparison with control group (150.8±49.1 and 497.2±123.0µg/L, respectively). Osteocalcin concentration significantly (p<0.001) decreased after 6 months in comparison with 3 months of treatment. ICTP did not change significantly.
Decreased PICP and osteocalcin concentration suggests the decreased rate of bone formation and might be clinically useful as a marker of early adverse effects of glucocorticoids on bone tissue.
Alergia Astma Immunologia, 2001, 6(2), 95-99


keywords: astma, budezonid, metabolizm kostny, dzieci, asthma, budesonide, bone metabolism, children

pages: from 95 to 99



estimated time of download (79 kB)
broadband speed:561282565121024[kbps]
time:176322[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.